首页 | 本学科首页   官方微博 | 高级检索  
     


Steroid-Responsive Rosai-Dorfman Disease
Authors:John I. Antonius   Salim M. Farid  Atilio Baez-Giangreco
Affiliation: a Department of Pathology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabiab Oncology Department, Maternity & Children's Hospital, Ministry of Health, Riyadh, Saudi Arabiac Department of Pathology, Riyadh Central Laboratory, Ministry of Health, Riyadh, Saudi Arabia
Abstract:Nodular skin lesions on the lateral aspects of the legs of a female child were first noticed at the age of 6 days. A biopsy of the lesions was done at the age of 6 months when the child had also developed cervical and inguinal lymphadenopathy and angiomatous lesions on the face. The diagnosis of Rosai-Dorfman disease (RDD; also known as sinus histiocytosis with massive lymphadenopathy, SHML) was made. Increasing respiratory obstruction by lymphoid tissue prompted a 2-week trial with oral prednisolone. A dramatic response occurred, with complete resolution of all clinical findings within 5 days, but with recurrence of lymphadenopathy 6 weeks after stopping with medication. Further observations over the next 3 years established a consistent response to prednisolone and a pattern of steroid dependence.
Keywords:bacillary angiomatosis  prednisolone  Rosai-Dorfman disease  sinus histiocytosis with massive lymphadenopathy  S100 protein
本文献已被 InformaWorld 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号